Previous Page  36 / 44 Next Page
Information
Show Menu
Previous Page 36 / 44 Next Page
Page Background

THE INVESTOR CENTRE

All information correct as at 30 June 2016

MANULIFE

Global Equity Income

Financial and healthcare sectors

returned positive results for portfolio

Global equities

gained groundduring

the secondquarter

MAJEDIE

UK Growth

Joint manager: UK & General Progressive

Anglo American, BP and Rentokil

Initial helped boost returns

Rally in commodities

overshadowedbyEU

referendumvote

MAJEDIE

UK Income

Dollar-earners Pearson and Genel

Energy helped portfolio performance

Negative sentiment

drivenbymarket

shock at Brexit result

T

he UK Income fund’s key positions

in nancials experienced negative

sentiment, initially from a‘buyers’

strike’ in the run-up to the UK

referendum, and then from the market

shock that ensued fromBrexit.

We halved our position in Lloyds

during the vote’s run-up.Key detractors

were Legal &General andAviva; but

we believe these stocks are 3-4 times

stronger than in the run-up to the 2008

crisis and that their business models are

unlikely to be a ected by Brexit; both

recently con rmed stable trading and

su cient balance-sheet capacity to

take account of market volatility.

Man Group had a weak quarter as

market volatility impacted performance

of its‘trend trading’AHL hedge fund;

but the product has also reported strong

ows.The stock has a net cash balance

sheet yieldingmore than 5%at present.

We have tilted the fund towards

‘dollar pro ts’ and this has helped

performance. Pearson led the way: its

earnings are mainly in dollars and it

has limited exposure to the UK.Genel

Energy, a non-UK oil company and

thus a dollar-earner,was in positive

territory.Tate & Lyle performed

favourably: it is probably the biggest

dollar-earner on the UK stock market.

A

fter a volatile Q1, global equities

largely advanced over the period.

Commodity prices gained, particularly

oil, providing a more stable backdrop

for equities.The timing of US Federal

Reserve Board interest rate increases

continued to be in focus and mixed

economic data was digested. European

markets keyed in on the potential

outcomes of the UK’s referendum.

Q1 company earnings were mixed

and reinforced the theme of slow

growth among major economies.

Stock selection within the nancials

and healthcare sectors contributed to

performance while the consumer

discretionary and industrials sectors

detracted

fromperformance.We

added Chubb and sold Kohl’s, Baxter

International,Akzo Nobel and

JPMorgan Chase.Our concerns are

de ation risk, excess debt and slowing

global growth.The Fed raised interest

rates in December 2015, but global

central bank monetary policy is

accommodative.We

remain cautious

that the stronger dollar, slow global

growth and de ationary pressures

couldoverwhelmtheUS

recovery.As

expected,Japan’s proposedconsumption

tax increase has been delayed. Further

stimulus may be needed.

T

he vociferous EU referendum

campaign overshadowed a quarter

in which commodities experienced a

rally and UK banks, prior to 23 June,

had attracted some positive sentiment.

The UK’s vote to leave the EU

shocked markets worldwide, greatly

heightening uncertainty.

BP andAngloAmerican were the top

performers quarter to date, as

investors covered their bearish

positions in oil and other commodities.

Rentokil Initial also boosted returns.

The trio were joined in positive

territory by Lloyds, following its

Supreme Court case win.

On the negative tack,Tesco’s CEO

dampened the outlook for the rate of

growth in the rst half of the year.

However, the retailer continues its

fruitful operational transformation and

should bene t from a potential rise in

food in ation stemming fromBrexit.

Ryanair su ered from referendum

sentiment, as the decline in sterling

hurts UK holidaymakers.The Royal

Bank of Scotland also weakened on

UK economic concerns.

As exible investors,we opened a

position in BritishAmericanTobacco,

which o ers defensive support during

a time of sterling weakness.

Richard Staveley, James de Uphaugh,

Matthew Smith and Chris Field

Chris Reid

Paul Boyne and Doug McGraw

36

|

THE INVESTOR